More Inoviq Ltd news
Inoviq LtdASX: IIQ

Positive EXO-NET Results in Ovarian Cancer

Dec 12, 2022 at 11:07 PM EST · Issued by Inoviq Ltd

Filed with ASX · Dec 12, 2022 at 11:07 PM EST · 3 pages · English

On 6ix: 6ix.com/news/positive-exo-net-results-in-ovarian-cancer

Inoviq Ltd on 6ix

Story so far

  • INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-outJul 21, 2022
  • INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer TestApr 1, 2022
  • Proof-of-Concept for SubB2M ELISA-Based Ovarian Cancer TestAug 17, 2021

Earlier from Inoviq

  • MST Access Diagnostics Forum PresentationDec 4, 2022
  • CEO AGM PresentationNov 27, 2022
  • INOVIQ Settles Legal ProceedingsNov 27, 2022
  • Commercial and R&D UpdateNov 24, 2022
  • Healthcare Conference Investor PresentationNov 10, 2022

Later from Inoviq

  • Appendix 4C & Quarterly Activities Report - December 2022Jan 30, 2023
  • Positive results for SubB2M Breast Cancer TestFeb 7, 2023
  • Appendix 4D and Half Year Financial ReportFeb 23, 2023
  • Appendix 4C and Quarterly Activities Report - March 2023Apr 27, 2023
  • ISEV Meeting PresentationsMay 18, 2023
All Inoviq news releases↗

Follow Inoviq into a list and get an email when it puts out news.

Follow Inoviq
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer